Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             227 results found
no title author magazine year volume issue page(s) type
1 A cell culture assay for compounds which inhibit hepatitis B virus replication Korba, B.E
1991
15 S1 p. 49-
1 p.
article
2 Activation of 2′-fluoro-2′,3′-dideoxyarabinosyladenine (FddA), an anti-HIV agent, in both quiescent and PHA-Activated Human Peripheral Blood Mononuclear Cells (PBMC) Ho, H.T.
1991
15 S1 p. 94-
1 p.
article
3 Activity of foscarnet versus ganciclovir-resistant cytomegalovirus (CMV) Drew, W.L
1991
15 S1 p. 108-
1 p.
article
4 Activity of HIV-I protease inhibitors in various enzymatic assays Roesel, J
1991
15 S1 p. 63-
1 p.
article
5 Activity of several inhibitors of S-adenosyl homocysteine hydrolase against African swine fever virus Villalón, D.G.
1991
15 S1 p. 74-
1 p.
article
6 Activity of tricyclic nucleoside and tricyclic nucleoside 5′ phosphate (Triciribine) against HIV and other retroviruses Kucera, L
1991
15 S1 p. 48-
1 p.
article
7 Acyclovir resistance in HSV-2 isolates from a patient with AIDS Bevilacqua, F.
1991
15 S1 p. 110-
1 p.
article
8 A modified guinea pig HSV-2 infection model designed to prevent ingestion of the topicallȳ applied antiviral drug R-837 Imbertson, L.M.
1991
15 S1 p. 135-
1 p.
article
9 Anabolism of 6-methoxypurine arabinoside in varicella-zoster virus (VZV) infected human fibroblasts de Miranda, P.
1991
15 S1 p. 145-
1 p.
article
10 An antisense oligonucleotide to the HSV-1 UL-13 gene is effective against herpetic keratitis Brandt, C.R.
1991
15 S1 p. 120-
1 p.
article
11 2′- and 5′-ester prodrugs of the varicella-zoster antiviral agent, 6-methoxypurine arabinoside Moorman, A.R
1991
15 S1 p. 146-
1 p.
article
12 An effective anti-influenzavirus combination of mopyridone and rimantadine hydrochloride Galabov, A.S.
1991
15 S1 p. 140-
1 p.
article
13 A novel RNA template for the study of antiretroviral drugs White, E.L.
1991
15 S1 p. 82-
1 p.
article
14 A novel soluble factor (HIF) from CEM T cell line induced by an extract from Pinus parvifllora Sieb et Zucc can inhibit the replication of human immunodeficiency virus in vitro Lai, Patrick K.
1991
15 S1 p. 70-
1 p.
article
15 Anti-adenovirus activity of 3′-fluoro-2′,3′-dideoxythymidine Selway, J.W.T.
1991
15 S1 p. 49-
1 p.
article
16 Anti-herpes activity of fatty acid nucleoside derivatives Winther, M.D
1991
15 S1 p. 57-
1 p.
article
17 Anti-HIV activity of iso-Trimethoprim analogues La Colla, P.
1991
15 S1 p. 65-
1 p.
article
18 Anti-HIV activity of sulfated polysaccharides from the brown seaweed Ascophyllum nodosum Klinger, M.M.
1991
15 S1 p. 69-
1 p.
article
19 Antimyxovirus activities of pyridobenzazole derivatives Shigeta, S
1991
15 S1 p. 48-
1 p.
article
20 Antirhinovirus spectrum and mechanism of action of R 77975 Andries, K.
1991
15 S1 p. 98-
1 p.
article
21 Antisense targeting of HIV RNA secondary structures Buckheit, R.W
1991
15 S1 p. 104-
1 p.
article
22 Antiviral activity of FIAU versus strains of CMV sensitive and resistant to ganciclovir Drew, W.L
1991
15 S1 p. 108-
1 p.
article
23 Antiviral activity of 5′-modified analogs of AZT against HIV-1 and 2 Freeman, G.A
1991
15 S1 p. 54-
1 p.
article
24 Antiviral activity of protease inhibitors in animal models of AIDS Black, PaulL.
1991
15 S1 p. 129-
1 p.
article
25 Antiviral activity of the SHS-174 plant preparation Serkedjieva, J.
1991
15 S1 p. 73-
1 p.
article
26 Antiviral research branch, NIAID in vitro antiviral screen and antiviral evaluation in animal models 1991
15 S1 p. 159-160
2 p.
article
27 Antiviral (RNA) evaluation of a series of substituted tyrosines Gabrielsen, B.
1991
15 S1 p. 67-
1 p.
article
28 A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection Last-Barney, K
1991
15 S1 p. 107-
1 p.
article
29 Associated activities, tours, accompanying persons 1991
15 S1 p. 8-
1 p.
article
30 A study of the degree of the influenza virus a sensitivity to RM antadine Kalnina, V.
1991
15 S1 p. 113-
1 p.
article
31 Asymmetric synthesis of 1,3-Dioxolane Nucleosides and their anti-HIV activities Chu, C.K
1991
15 S1 p. 43-
1 p.
article
32 A three-dimensional model to analyze drug-drug interactions Prichard, M.N.
1991
15 S1 p. 114-
1 p.
article
33 Aurintricarboxylic acid: An inhibitor of herpes simplex types I and II, vaccinia and African swine fever viruses replication in vero cells Gil-Fernández, C.
1991
15 S1 p. 75-
1 p.
article
34 Author index 1991
15 S1 p. 155-
1 p.
article
35 3′-azido-2′3′-dideoxythymidine (AZT) inhibits proliferation of normal bone marrow progenitor cells by reducing mitochondrial biogenesis Lewis, L.D.
1991
15 S1 p. 148-
1 p.
article
36 4′-Azidothymidine: Synthesis and in vitro anti-HIV activity Maag, H
1991
15 S1 p. 10-42
33 p.
article
37 Capsaicin reduces the zosteriform spread of genital herpes simplex virus infection in guinea pigs Stanberry, L.R.
1991
15 S1 p. 137-
1 p.
article
38 Cardiolipin liposomes specifically inhibit HIV-1 infectivity Konopka, K.
1991
15 S1 p. 68-
1 p.
article
39 Cellular pharmacology of 2′,3′-didehydro-2′,3′-dideoxythymidine (D4T) in human bone marrow progenitor cells (HBMC) Zhu, Z.
1991
15 S1 p. 152-
1 p.
article
40 Characterization of the anti-human Cytomegalovirus (HCMV) activity of three anthraquinone compounds Barnard, D.L
1991
15 S1 p. 99-
1 p.
article
41 Combined antiviral effect and cytotoxicity of ganciclovir and azidothymidine against cytomegalovirus infection in cultured cells Tian, P.Y.
1991
15 S1 p. 114-
1 p.
article
42 COMBO: A new approach to the design and analysis of experiments on antiviral drug combinations Weinstein, J.N.
1991
15 S1 p. 113-
1 p.
article
43 Comparative antiviral activity of HPMPA, PMEA, HPMPG, HPMPC and structurally related compounds against African swine fever virus La Colla, P.
1991
15 S1 p. 65-
1 p.
article
44 Comparison of anti-proliferative activity of selected antiviral agents in human cell lines and a bone marrow cell assay Hartline, C.B
1991
15 S1 p. 148-
1 p.
article
45 Conference committees 1991
15 S1 p. 3-
1 p.
article
46 Corporate sponsors 1991
15 S1 p. 5-
1 p.
article
47 Crosslinking of substrates occurs exclusively to the p66 subunit of heterodimeric HIV-1 reverse transcriptase Cheng, N.
1991
15 S1 p. 87-
1 p.
article
48 CTC 23 efficacy in vitro and on HSV-1-induced ocular epithelial and stromal disease in the rabbit Dunkel, E.C.
1991
15 S1 p. 134-
1 p.
article
49 Currency exchange 1991
15 S1 p. 8-
1 p.
article
50 2′-Deoxy-2′-fluoropyrimidine nucleosides with antiviral activity Slater, M.J.
1991
15 S1 p. 51-
1 p.
article
51 Design, synthesis and configuration of 5-[2,2-Dichloro )or 2-chloro) cyclopropyl]-2′-deoxyuridines Knaus, E.E
1991
15 S1 p. 44-
1 p.
article
52 Development of a competitive, enzyme-linked immunosorbent assay for the quantitation of antiviral agent 348U87 Orban, B
1991
15 S1 p. 144-
1 p.
article
53 Development of an animal model for ocular adenoviral infection Gordon, Y.J.
1991
15 S1 p. 119-
1 p.
article
54 Development of a neural cell line/HIV-1 infection system for evaluation of antiviral compounds Volsky, D.J.
1991
15 S1 p. 75-
1 p.
article
55 Development of an in situ -based hybridization format for the in vitro evaluation of antiviral compounds Forman, M.
1991
15 S1 p. 76-
1 p.
article
56 Dextran sulfate and other sulfated polysaccharides induce persistent HIV-1 infection Buckheit Jr., RobertW.
1991
15 S1 p. 68-
1 p.
article
57 2,3-Dideoxyfuranoses in convergent syntheses of 2′,3′-dideoxy nucleoside Pedersen, E.B
1991
15 S1 p. 56-
1 p.
article
58 Differential inhibitory effects of sulfated polysaccharides on the replication of various myxo- and retroviruses Hosoya, M.
1991
15 S1 p. 91-
1 p.
article
59 Duck hepatitis B virus DNA polymerase: Comparison of the main properties of different enzyme preparations and the inhibition by some inhibitors Tao, P.Z.
1991
15 S1 p. 98-
1 p.
article
60 Ebola infected SCID mice as a model for drug evaluation Zhang, Z.X.
1991
15 S1 p. 139-
1 p.
article
61 Editorial Board 1991
15 S1 p. ii-
1 p.
article
62 Effect of AZT, AzddU, FDT, and BCH-189 nucleotides on DNA chain termination mediated by HIV-1 reverse transcriptase Schinazi, R.F.
1991
15 S1 p. 96-
1 p.
article
63 Effect of indomethacin on UV-induced recurrent genital HSV-2 disease in the guinea pig Harrison, C.J.
1991
15 S1 p. 136-
1 p.
article
64 Effect of topical treatment with HPMPC on genital herpes simplex virus type 2 (HSV-2) infections of guinea pigs or mice Vogt, P.E.
1991
15 S1 p. 137-
1 p.
article
65 Effects of 2′3′-dideoxycytidine (DDC) an anti HIV-1 nucleoside analogue on mitochondrial biogenesis, structure and function Lewis, L.D.
1991
15 S1 p. 149-
1 p.
article
66 Effects of ribosome inactivating proteins against herpesviruses Foung, S.K.H.
1991
15 S1 p. 77-
1 p.
article
67 Efficacy of a recombinant human interferon alpha B/D hybrid (IFN-αB/D) against experimental genital herpes infection in male and female guinea pigs Cozens, R.M.
1991
15 S1 p. 135-
1 p.
article
68 Efficacy of oral treatment with BV-araU against cutaneous infection with herpes simplex type 1 in shaved mice Machida, H.
1991
15 S1 p. 138-
1 p.
article
69 Efficacy of short term continuous Zidovudine infusion at early stages of retroviral infection in mice Sinet, M.
1991
15 S1 p. 127-
1 p.
article
70 Efficacy of ( S )-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [HPMPC] against intraperitoneal and intracerebral murine cytomegalovirus infections Neyts, J.
1991
15 S1 p. 133-
1 p.
article
71 Efficiency of antioxidant agents in prevention and treatment of experimental influenza in mice Chetverikova, L.
1991
15 S1 p. 142-
1 p.
article
72 Elucidation of a polyphenolic polymer with antiviral activity against myxo- and paramyxoviruses Wyde, P.R.
1991
15 S1 p. 67-
1 p.
article
73 Enhanced inhibition of HIV-1 protease by a combination of peptide and non-peptide inhibitors Luftig, R.B.
1991
15 S1 p. 66-
1 p.
article
74 Evaluation of antiretroviral drugs against Rauscher MuLV by ELISA Hollingshead, M.
1991
15 S1 p. 69-
1 p.
article
75 Evaluation of antiviral compounds against human CMV in a mouse model Allen, L.B.
1991
15 S1 p. 133-
1 p.
article
76 Evaluation of immunotoxic potential of antiviral drugs: Effects of DHPG and HPMPC on lymphocyte transformation and delayed-type hypersensitivity (DTH) responses Simecka, J.W
1991
15 S1 p. 150-
1 p.
article
77 Evaluation of some novel compounds for anti-HIV and anti-influenza activity Broadhurst, K.
1991
15 S1 p. 72-
1 p.
article
78 Evaluation of structure-activity relation between (E)-5-(2-bromovinyl)-and 5-vinyl-1-B-D-arabinofuranosyluracil (BV-araU, V-araU) in inhibition of Epstein-Barr virus replication Lin, J.C
1991
15 S1 p. 63-
1 p.
article
79 Feline immunodeficiency virus: A lentivirus model for chemotherapy of AIDS and drug-resistance North, ThomasW.
1991
15 S1 p. 122-
1 p.
article
80 Further studies on the HIV proteinase inhibitor RO 31-8959 Galpin, S.
1991
15 S1 p. 96-
1 p.
article
81 GAG and REV antisense oligodeoxynucleotides as inhibitors of HIV 1 Kinchington, D.
1991
15 S1 p. 88-
1 p.
article
82 Ganciclovir antagonizes the anti-HIV-1 activity of zidovudine in vitro Medina, D.J.
1991
15 S1 p. 115-
1 p.
article
83 Ganciclovir is a potent inhibitor of duck hepatitis B virus replication in vivo Shaw, Tim
1991
15 S1 p. 131-
1 p.
article
84 General information 1991
15 S1 p. 6-
1 p.
article
85 Genital herpes simplex virus (HSV) infections of mice: A model for evaluating cross susceptibility of drug resistant mutants Kern, E.R.
1991
15 S1 p. 121-
1 p.
article
86 GLQ223® exacerbation of indirect HIV-associated neurotoxicity in vitro Pulliam, L.
1991
15 S1 p. 82-
1 p.
article
87 Herpes simplex virus type 1 helicase-primase: Inhibition by N2-phenylguanines, 2-anilinoadenines and related compounds Wright, G.E
1991
15 S1 p. 102-
1 p.
article
88 Human immunodeficiency virus (HIV) replication: Modulation by cellular levels of cyclic adenosine monophosphate (cAMP) Nokta, M.A.
1991
15 S1 p. 89-
1 p.
article
89 Human monoclonal anti Cytomegalovirus (CMV) antibody (MSL-109): Enhancement of in vitro ganciclovir induced inhibition of CMV replication Nokta, M.A.
1991
15 S1 p. 76-
1 p.
article
90 Induction of neutralizing antibodies to interferon during treatment of hepatitis patients: Comparison among different interferon preparations Duanzani, F.
1991
15 S1 p. 126-
1 p.
article
91 Influence of template primary structure of 3′-azido-3′-deoxythymidine triphosphate (AZT-TP) incorporation into genomic DNA Bridges, E.G.
1991
15 S1 p. 123-
1 p.
article
92 Inhibition of coxsackie, echo and hepatitis A virus infection by polyelectrolytes Seganti, L.
1991
15 S1 p. 78-
1 p.
article
93 Inhibition of duck hepatitis B virus replication by ganciclovir and supercoiled DNA active compounds Shaw, Tim
1991
15 S1 p. 121-
1 p.
article
94 Inhibition of ebola virus replication in vitro and in a SCID mouse model by S-adenosylhomocysteine hydrolase inhibitors Huggins, J.W.
1991
15 S1 p. 122-
1 p.
article
95 Inhibition of herpes simplex virus replication by antisense Cantin, E.M.
1991
15 S1 p. 118-
1 p.
article
96 Inhibition of HIV and DHBV reverse transcriptase by extracts or components of Chinese traditional medicines and herbs Chen, H.S.
1991
15 S1 p. 62-
1 p.
article
97 Inhibition of HIV protease activity by various dipeptide isosteres Fässler, A
1991
15 S1 p. 55-
1 p.
article
98 Inhibition of HIV replication by prostaglandin A Ankel, H.
1991
15 S1 p. 71-
1 p.
article
99 Inhibition of HSV-1 DNA polymerase by (R)-(1α,2β,3α)-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine and (S)-(1α,2β,3α)-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine Hagen, M.E
1991
15 S1 p. 99-
1 p.
article
100 Inhibition of HSV-2 replication and glycoprotein expression in human fibroblast cells by HPMC Chatterjee, S.
1991
15 S1 p. 102-
1 p.
article
101 Inhibition of poly (ADP-ribose) polymerase by various antiviral and anticancer nucleoside analogs Pivazyan, Arman D
1991
15 S1 p. 105-
1 p.
article
102 Inhibition of Sindbis virus replication by prostaglandins: a cell-mediated event associated with heat shock protein synthesis Mastromarino, P.
1991
15 S1 p. 97-
1 p.
article
103 Inhibition of the human immunodeficiency virus type 1 reverse transcriptase by 2′-deoxynucleoside-5′-triphosphate substrates Furman, P.A.
1991
15 S1 p. 92-
1 p.
article
104 Inhibitors of herpes simplex thymidine kinase suppress reactivation of latent infection in vitro Klavinskis, L.S.
1991
15 S1 p. 103-
1 p.
article
105 Inhibitory activity of lipophilic 2′,3′-dideoxynucleoside derivatives against HIV Winther, M.D.
1991
15 S1 p. 66-
1 p.
article
106 Initial binding of 2′-deoxynucleoside-5′-triphosphates to HIV-1 reverse transcriptase Painter, G.
1991
15 S1 p. 80-
1 p.
article
107 Interaction of the 5′-triphosphate of the carbocyclic analog of 2′-deoxyguanosine with human immunodeficiency virus type-1 reverse transcriptase Parker, WilliamB.
1991
15 S1 p. 93-
1 p.
article
108 Intracellular immunization against HIV-1 by poly-TAR RNA elements Lisziewicz, J.
1991
15 S1 p. 88-
1 p.
article
109 Intravenous dextran sulfate (DS) increases circulating HIV antigen levels in patients with ARC or AIDS Flexner, C.
1991
15 S1 p. 125-
1 p.
article
110 Introduction to sponsors 1991
15 S1 p. 4-
1 p.
article
111 In vitro and in vivo characterization of herpes simplex virus isolates recovered from HIV+ patients Hill, E.L.
1991
15 S1 p. 111-
1 p.
article
112 In vitro antiviral activity, cytotoxicity, and metabolism of 5-bromo and 5-iodo tubercidin analogs Nassiri, M.R.
1991
15 S1 p. 101-
1 p.
article
113 In vitro exposure of cytomegalovirus (CMV)-infected cells to high concentrations of acyclovir (ACV) induces resistance to ganciclovir (GCV) Dworkin, R.J
1991
15 S1 p. 107-
1 p.
article
114 In vitro neutralization of Cytomegalovirus (CMV) strains by a human monoclonal antibody, MSL-109 Lakeman, F.
1991
15 S1 p. 77-
1 p.
article
115 In vitro pharmacodynamic modeling of anti-retroviral agents and interferon Bilello, J.A.
1991
15 S1 p. 151-
1 p.
article
116 In vitro sensitivity of rhinovirus infection to new flavanoids Conti, C.
1991
15 S1 p. 79-
1 p.
article
117 In vivo antiviral efficacy of oral ganciclovir Drew, W.L.
1991
15 S1 p. 127-
1 p.
article
118 In vivo inhibition of HBsAg and DHBsAg expression in ducks after injection of HBsAg or DHBsAg antisense vaccinia recombinant Chen, H.S.
1991
15 S1 p. 132-
1 p.
article
119 Kinetic analysis of the inhibition of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase by R82150, a TIBO analog Connell, E.V.
1991
15 S1 p. 90-
1 p.
article
120 Lack of retinal toxicity of the anti-CMV drug ( S )-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) Dolnack, D.R.
1991
15 S1 p. 149-
1 p.
article
121 Latent infection with an herpes simplex virus type 1 resistant to acyclovir Katz, E.
1991
15 S1 p. 109-
1 p.
article
122 Lithium resistant herpes virus mutant Randall, S
1991
15 S1 p. 110-
1 p.
article
123 Low molecular weight difluoroketones that are inhibitors of HIV-1 protease and with antiviral activities in vitro Sham, H.
1991
15 S1 p. 53-
1 p.
article
124 Masked nucleotides: A strategy to introduce therapeutic nucleoside 5′-phosphates into cells Farquhar, D.
1991
15 S1 p. 143-
1 p.
article
125 Mechanism of action of ribavirin Patterson, J.L.
1991
15 S1 p. 97-
1 p.
article
126 Mechanism of the inhibitory effect of 4′-azido-thymidine (ADRT) on the replication of human immunodeficiency virus in vitro Chen, M.S.
1991
15 S1 p. 91-
1 p.
article
127 Meeting registration 1991
15 S1 p. 7-
1 p.
article
128 Metabolism and pharmacokinetics of the anti-varicella-zoster virus agent 6-dimethylaminopurine arabinoside Lambe, C.U.
1991
15 S1 p. 147-
1 p.
article
129 Ming-Chu Hsu Schutt, A.
1991
15 S1 p. 87-
1 p.
article
130 Minimum high dose ribavirin aerosol for the treatment of influenza in mice and respiratory syncytial virus in cotton rats Gilbert, B.E.
1991
15 S1 p. 142-
1 p.
article
131 Modulation of phagocytic and bactericidal activities in alveolar macrophages from influenza infected mice Pozdeev, O.K
1991
15 S1 p. 154-
1 p.
article
132 Modulation of the antiretroviral activity and anabolism of purine-2′,3′dideoxynucleoside analogs by inhibitors of IMP dehydrogenase Bondoc Jr., L.L.
1991
15 S1 p. 79-
1 p.
article
133 Morphopathogenesis of influenza a pneumonia in mice treated with LY217896 or amantadine Engelhardt, J.A
1991
15 S1 p. 141-
1 p.
article
134 MSL-109 therapy of human cytomegalovirus-induced chorioretinitis in the rabbit Dunkel, E.C.
1991
15 S1 p. 120-
1 p.
article
135 Multiple methods for the analysis of inhibitors of HIV-1 TAT-dependent transactivation Thais, T.W.
1991
15 S1 p. 103-
1 p.
article
136 Negatively charged albumins exhibit a potent invitro anti-HIV-1 activity and a unique inhibitory action on syncytium formation Jansen, R.W.
1991
15 S1 p. 81-
1 p.
article
137 New antiretrovical acyclic nucleotide analog: (R)-2′-Me-PMEG ((R)-N9(2-phosphonylmethoxypropylguanine) Yang, H.
1991
15 S1 p. 130-
1 p.
article
138 New antiretroviral agent: Phosphonate isostere of D4A-monophosphate Yang, H.
1991
15 S1 p. 130-
1 p.
article
139 New models of murine cytomegalovirus infection in immunocompromised mice Smee, D.F.
1991
15 S1 p. 132-
1 p.
article
140 Novel 6-alkoxypurine-2′,3′-dideoxynucleosides as inhibitors of the human immunodeficiency virus Burns, C.L.
1991
15 S1 p. 52-
1 p.
article
141 Novel azolylalkyloxy heterocyces as potential antipicornavirus agents Daneshtalab, M.
1991
15 S1 p. 45-
1 p.
article
142 Novel modified nucleosides and their phosphorylated analogues as potential anti-HIV agents Nair, V
1991
15 S1 p. 44-
1 p.
article
143 Novel non-nucleoside inhibition of reverse transcriptase (RT) for human immunodeficiency virus-1 (HIV-1) Adams, J.
1991
15 S1 p. 45-
1 p.
article
144 N2-phenylguanines as inhibitors of HSV thymidine kinases: Potential for prevention of recurrent herpes infections Wright, G.E.
1991
15 S1 p. 84-
1 p.
article
145 Nucleoside HIV-antiviral agents incorporating degenerate bases Loakes, D
1991
15 S1 p. 60-
1 p.
article
146 2′,5′-Oligoadenylate analogues prevent HIV replication via inhibition of reverse transcriptase Müller, W.E.G.
1991
15 S1 p. 89-
1 p.
article
147 On the specificity of the 2-5A phosphodiesterase Kovács, Teréz
1991
15 S1 p. 94-
1 p.
article
148 Pattern of resistance against AZT-resistant HIV-1 in human peripheral blood mononuclear cells Schinazi, R.F.
1991
15 S1 p. 83-
1 p.
article
149 Penciclovir: Mode of action studies in HSV-1, HSV-2, and VZV infected MRC-5 cells Vere Hodge, R.A.
1991
15 S1 p. 100-
1 p.
article
150 Photo-arbuzov route to acyclic nucleoside-based phosphanates Bentrude, WesleyG.
1991
15 S1 p. 57-
1 p.
article
151 Potent and selective anti-retrovirus activity of 9-(RS)-(3-fluoro-2-phosphonylmethoxypropyl) purine derivatives Balzarini, J
1991
15 S1 p. 46-
1 p.
article
152 Potent anti-HIV activity of some phosphate derivatives of AZT McGuigan, C.
1991
15 S1 p. 71-
1 p.
article
153 Potentiation by dipyridamole of dideoxynucleoside activity against HIV-1: differential effects on salvage of deoxy- and dideoxy-nucleosides as a possible mechanism Szebeni, J.
1991
15 S1 p. 95-
1 p.
article
154 Potentiation of the anti-HIV activity of ddAdo by coformycin, EHNA and deaza-EHNA derivatives La Colla, P.
1991
15 S1 p. 124-
1 p.
article
155 Protection of zidovudine (AZT)-induced fetal toxicity in mice by interleukin-3 (IL-3) Gogu, S.R
1991
15 S1 p. 150-
1 p.
article
156 Proteolytic processing of the conserved V3 region of HIV GP120 by T-cell lysates. Implications for HIV infectivity Krafft, GrantA.
1991
15 S1 p. 104-
1 p.
article
157 4-Quinolones do not inhibit the nickase activity of HIV integrase Pemberton, I.K.
1991
15 S1 p. 72-
1 p.
article
158 Racemic and acyclic analogues of D4 nucleosides: Synthesis and antiviral evaluation Imbach, J.-L
1991
15 S1 p. 60-
1 p.
article
159 Rapid screening of clinical herpes simplex virus isolates for resistance to acyclovir Ketchum, D.G.
1991
15 S1 p. 111-
1 p.
article
160 Receptor targeted inhibition of HIV-I RNA production in cells by an IL-2 diptheria toxin fusion protein Zhang, L.
1991
15 S1 p. 86-
1 p.
article
161 Reduction of herpes simplex virus infection using phosphorothioate oligonucleotides complementary to viral mRNA Draper, K.G
1991
15 S1 p. 106-
1 p.
article
162 Resistance of HCMV to DHPG, HPMPC and HPMPA mapped to the viral DNA polymerase gene Sullivan, V.
1991
15 S1 p. 84-
1 p.
article
163 Ribavirin therapy for SSPE virus infection in hamster Honda, Y.
1991
15 S1 p. 139-
1 p.
article
164 Rimantadine (RIMA) in nasal secretions impairs accurate virus quantitation in humans undergoing antiviral treatment Atmar, R.L
1991
15 S1 p. 153-
1 p.
article
165 RNA-dependent DNA polymerases (Reverse Transcriptases) of normal cells: A possible basis for nucleotide analogue toxicities? Hart, D.J
1991
15 S1 p. 105-
1 p.
article
166 R837 treatment of recurrent genital HSV-2 disease in the guinea pig Harrison, C.J
1991
15 S1 p. 136-
1 p.
article
167 SCID mice engrafted with HIV-infected human T4-lymphocytes as an in vivo model for the evaluation of anti-HIV drugs Naesens, L.
1991
15 S1 p. 128-
1 p.
article
168 Scientific program 1991
15 S1 p. 9-
1 p.
article
169 Screening of anti-retroviral drugs based on inhibition of transformative-destructive effect of mouse sarcoma virus in cell culture Sinyagina, E.A.
1991
15 S1 p. 73-
1 p.
article
170 Selective inhibition of alpha-, arena-, bunya-, and flaviviruses by 3′-fluoro-3′-deoxyadenosine Smee, D.F.
1991
15 S1 p. 62-
1 p.
article
171 Selective phosphorylation of 6-dimethylamino-9-(β-D-arabinofuranosyl)-9H-purine(ara-DMAP) in varicella-zoster virus infected human foreskin fibroblast cells Nelson, D.J.
1991
15 S1 p. 146-
1 p.
article
172 Sensitivity of mutated herpes simplex virus type-1 DNA polymerase to conventional guanine and novel cyclobutane guanine nucleotide analogues Stevens, J.T.
1991
15 S1 p. 109-
1 p.
article
173 Sequence analysis of the thymidine kinase genes of acyclovir-resistant varicella zoster virus isolates Talarico, C.
1991
15 S1 p. 112-
1 p.
article
174 Short and stereoselective synthesis of a new bioisoster of 2′,3′- dideoxy adenosine monophosphate Halazy, S.
1991
15 S1 p. 55-
1 p.
article
175 Site of action of 9-/1,3-dihydroxy-2-propoxymethyl/guanine/DHPG/ in the virus replication cycle Dragúň, M.
1991
15 S1 p. 101-
1 p.
article
176 Social functions 1991
15 S1 p. 8-
1 p.
article
177 Stilbene disulfonic acids: CD4 antagonists that block human immunodeficiency virus type-1 growth at multiple stages of the virus life cycle Cardin, A.D.
1991
15 S1 p. 125-
1 p.
article
178 Structural design and anti-HIV-1 evaluation of novel naphthalenedisulfonic acid derivatives Mohan, P.
1991
15 S1 p. 61-
1 p.
article
179 Structure and activity correlation-studies of anti-HIV acyclic guanine nucleotide analogs at enzyme level Ho, H.-T.
1991
15 S1 p. 95-
1 p.
article
180 Structure-based drug design: Inhibitors of purine nucleoside phosphorylase (PNP) Secrist III, J.A
1991
15 S1 p. 106-
1 p.
article
181 Subcellular localization and antiviral activity of cationic dye/poly r(A-U) combinations Krabill, K
1991
15 S1 p. 64-
1 p.
article
182 6-substituted purine arabinosides as selective and potent inhibitors of varicella-zoster virus Koszalka, G.W.
1991
15 S1 p. 145-
1 p.
article
183 Synergistic effects of 3-deazaneplanocin A, carbocyclic 3-deazaadenosine, neplanocin A and ribavirin against measles virus Pfeifer, J.B.
1991
15 S1 p. 116-
1 p.
article
184 Synergistic inhibition of drug-resistant and -sensitive herpes simplex virus in vitro by trifluorothymidine and interferon alpha Birch, C.
1991
15 S1 p. 117-
1 p.
article
185 Synergistic inhibition of human immunodefficiency virus type 1 in vitro by coumermycin A1 and human leukocyte interferon Tachedjian, G.
1991
15 S1 p. 117-
1 p.
article
186 Synergistic interactions between lithium and nucleoside analogue antiviral compounds Randall, S.
1991
15 S1 p. 115-
1 p.
article
187 Synthesis and anti-RSV activities of novel nucreosides: 6-Substituted analogs of 2′,3′-dideoxypurine nucreosides Machida, M.
1991
15 S1 p. 53-
1 p.
article
188 Synthesis and antiviral activity of new disoxaril analogues La Colla, P.
1991
15 S1 p. 64-
1 p.
article
189 Synthesis and biological evaluation of an acyclic thiosangivamycin Renau, T.E
1991
15 S1 p. 47-
1 p.
article
190 Synthesis and properties of bithiazole-linked netropsin derivatives Imbach, J.-L
1991
15 S1 p. 59-
1 p.
article
191 Synthesis and properties of novel derivatives of 1,N-2-bridged acyclovir and DHPG Golankiewicz, B
1991
15 S1 p. 59-
1 p.
article
192 Synthesis of 2-amino-9-(3′-azido-2′,3′-dideoxy-beta-D-erythro-pentofuranosyl)-6-methoxy-9H purine (AzddMAP) and AzddGuo Almond, M.R.
1991
15 S1 p. 54-
1 p.
article
193 Synthesis of C- and N-nucleosides and use of distance geometry approach for the evaluation of in vitro antiviral activity Kobe, J
1991
15 S1 p. 58-
1 p.
article
194 Synthesis of some mimics of nucleoside triphosphates Coe, D.M
1991
15 S1 p. 52-
1 p.
article
195 Synthesis of some uridine and 2′-deoxyUridine 5-N-alkoxycarbonylcarboxamides Shaw, G.
1991
15 S1 p. 50-
1 p.
article
196 Synthetic inhibitors of HIV-1 protease inhibit virus maturation and infectivity of virions Lambert, D.M.
1991
15 S1 p. 81-
1 p.
article
197 The activity of Brequinar, an inhibitor of de novo pyrimidine biosynthesis, against human cytomegalovirus replication Hamzeh, F.M.
1991
15 S1 p. 61-
1 p.
article
198 The anti-HCMV potential of carbocyclic 3′-deoxypurine nucleosides Schneller, S.W
1991
15 S1 p. 56-
1 p.
article
199 The anti-HIV-1 activity of CD4 synthetic oligopeptides is not related to gpl20 binding Palu', G.
1991
15 S1 p. 92-
1 p.
article
200 The antiviral activities of monoclonal antibodies to antigenic site 3A of poliovirus type 1 Sabin acts synergistically with the antiviral activity of interferon-α (IFN-α) Langford, M.P.
1991
15 S1 p. 118-
1 p.
article
201 The anti-VZV agent 6-methoxypurine arabinoside: Neurotoxic effects in 90-day oral studies in monkeys and rats given a prodrug Szczech, G.M.
1991
15 S1 p. 147-
1 p.
article
202 The anti-VZV agent 6-methoxypurine arabinoside: Synthesis, mechanism of action, prodrug development, and preclinical toxicity Koszalka, G.W.
1991
15 S1 p. 83-
1 p.
article
203 The assessment of the broad spectrum in vitro antiviral activity of a series of organogermanium compounds Taylor, R.C.
1991
15 S1 p. 74-
1 p.
article
204 The effect of age on the outcome of neonatal HSV infection in guinea pigs Mani, C.
1991
15 S1 p. 138-
1 p.
article
205 The efficacy of combinative drugs at sub-threshold concentrations Randall, S.
1991
15 S1 p. 116-
1 p.
article
206 The fifth international conference on antiviral research 1991
15 S1 p. 156-158
3 p.
article
207 The inhibition effects of catechin derivatives on the activities of human immunodeficiency virus reverse transcriptase and DNA polymerases Tao, P.Z.
1991
15 S1 p. 70-
1 p.
article
208 The molecular effect of lithium on herpes simplex virus replication Randall, S.
1991
15 S1 p. 100-
1 p.
article
209 Therapy of herpetic stromal keratitis by an antisense oligonucleotide analogue in a mouse model of ocular disease Metcalf, JosephF.
1991
15 S1 p. 134-
1 p.
article
210 The suppression of p24 antigenemia in the HIV-1 xenotransplanted nude mouse by azidothymidine Wetherall, N.T.
1991
15 S1 p. 129-
1 p.
article
211 The synthesis and antiviral properties of some 2′-deoxy-4′-thio-ribonucleoside analogues Dyson, M.R.
1991
15 S1 p. 78-
1 p.
article
212 The synthesis of 1-phosphonylmethoxyethyl-1,2,4-triazole-3-carboxamide, a new and novel acyclic nucleotide analog Kwong, C.D
1991
15 S1 p. 58-
1 p.
article
213 The TIBO-site on HIV-1 reverse transcriptase represents a new target for anti-HIV chemotherapy Pauwels, R.
1991
15 S1 p. 85-
1 p.
article
214 The transport of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) into vero cells Prus, K.L.
1991
15 S1 p. 143-
1 p.
article
215 The treatment of interferon with different dosages for chronic hepatitis B Zhang-qi, Wu
1991
15 S1 p. 153-
1 p.
article
216 TIBO derivatives are potent inhibitors of HIV-1 reverse trancriptase with heteropolymer templates White, E.L.
1991
15 S1 p. 93-
1 p.
article
217 Transport of the anti-varicella zoster agent, 6-methoxypurine arabinoside and its 2′-O-valerate prodrug human erythrocytes Prus, K.L.
1991
15 S1 p. 144-
1 p.
article
218 Travel arrangement 1991
15 S1 p. 7-
1 p.
article
219 Treatment of acyclovir (ACV)-resistant zoster with foscarnet in a man with AIDS Paar, DavidP.
1991
15 S1 p. 152-
1 p.
article
220 Treatment of chronic carriers of woodchuck hepatitis virus infection with thymosin alpha-1 Korba, Brent
1991
15 S1 p. 131-
1 p.
article
221 Treatment of mice infected with influenza and parainfluenza viruses by aerosolized aprotinin Zhirnov, O.P.
1991
15 S1 p. 141-
1 p.
article
222 Treatment of Phlebovirus infections of mice by poly ICLC Huffman, J.H.
1991
15 S1 p. 140-
1 p.
article
223 Trends in antiviral and AIDS therapeutics patents and research and development Rader, R.A
1991
15 S1 p. 154-
1 p.
article
224 Use of flow cytometry to monitor the expression of HIV p24 antigen in PBMC obtained from HIV-seropositive individuals undergoing antiviral chemotherapy McSharry, J.
1991
15 S1 p. 126-
1 p.
article
225 Use of SIV and HIV-2 infected monkeys in the evaluation of drugs against HIV/AIDS Öberg, B
1991
15 S1 p. 151-
1 p.
article
226 Utilization of pulse oximetry for study of potential anti-influenza virus compounds in mice Sidwell, R.W.
1991
15 S1 p. 123-
1 p.
article
227 Zidovudine (AZT) resistance in a cohort of patients at the London hospital Broadhurst, K.
1991
15 S1 p. 112-
1 p.
article
                             227 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands